Current Ratio in % of Arcutis Biotherapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Arcutis Biotherapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2020 to Q3 2025.
  • Arcutis Biotherapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 357%, a 32% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Arcutis Biotherapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 357% -164% -32% 30 Sep 2025
Q2 2025 316% -493% -61% 30 Jun 2025
Q1 2025 383% -422% -52% 31 Mar 2025
Q4 2024 472% -322% -41% 31 Dec 2024
Q3 2024 521% -388% -43% 30 Sep 2024
Q2 2024 809% -275% -25% 30 Jun 2024
Q1 2024 805% -341% -30% 31 Mar 2024
Q4 2023 794% -379% -32% 31 Dec 2023
Q3 2023 910% -277% -23% 30 Sep 2023
Q2 2023 1084% -191% -15% 30 Jun 2023
Q1 2023 1146% -446% -28% 31 Mar 2023
Q4 2022 1174% -897% -43% 31 Dec 2022
Q3 2022 1187% -1043% -47% 30 Sep 2022
Q2 2022 1275% -631% -33% 30 Jun 2022
Q1 2022 1592% +85% +5.6% 31 Mar 2022
Q4 2021 2071% +783% +61% 31 Dec 2021
Q3 2021 2230% +878% +65% 30 Sep 2021
Q2 2021 1906% 30 Jun 2021
Q1 2021 1507% 31 Mar 2021
Q4 2020 1287% 31 Dec 2020
Q3 2020 1352% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.